[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2055104T3 - Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap. - Google Patents

Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.

Info

Publication number
ES2055104T3
ES2055104T3 ES89312361T ES89312361T ES2055104T3 ES 2055104 T3 ES2055104 T3 ES 2055104T3 ES 89312361 T ES89312361 T ES 89312361T ES 89312361 T ES89312361 T ES 89312361T ES 2055104 T3 ES2055104 T3 ES 2055104T3
Authority
ES
Spain
Prior art keywords
fap
preparing
procedure
compound
antagonist activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312361T
Other languages
English (en)
Inventor
Aiya Sato
Michihiro Sugano
Kouhei Furuya
Takeshi Oshima
Harumitsu Kuwano
Tadashi Hata
Hideyuki Haruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2055104T3 publication Critical patent/ES2055104T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRESENTAN UNA SERIE DE NUEVOS COMPUESTOS, LLAMADOS "PHOMACTINS" QUE PUEDEN SER AISLADOS DEL CALDO DE CULTIVO DE HONGOS DEL GENERO "PHOMA" ESPECIALMENTE "PHOMA SP." SANK 11486 (NO. FERM BP-2598). ESTOS COMPUESTOS SON ANTAGONISTAS DE FACTOR ACTIVADOR Y PUEDEN USARSE EN EL TRATAMIENTO DE ENFERMEDADES PARA LAS CUALES LOS AGENTES CONOCIDOS PUEDEN TAMBIEN USARSE.
ES89312361T 1988-11-28 1989-11-28 Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap. Expired - Lifetime ES2055104T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30027888 1988-11-28

Publications (1)

Publication Number Publication Date
ES2055104T3 true ES2055104T3 (es) 1994-08-16

Family

ID=17882866

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312361T Expired - Lifetime ES2055104T3 (es) 1988-11-28 1989-11-28 Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.

Country Status (7)

Country Link
US (1) US5151529A (es)
EP (1) EP0371762B1 (es)
KR (1) KR940004128B1 (es)
AT (1) ATE88707T1 (es)
CA (1) CA2003956A1 (es)
DE (1) DE68906248T2 (es)
ES (1) ES2055104T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2227369A1 (en) * 1995-07-25 1997-02-13 Fernando Pelaez Inhibitors of farnesyl-protein transferase
US5663193A (en) * 1995-07-25 1997-09-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP4123106B2 (ja) 2003-08-22 2008-07-23 ソニー株式会社 有機el素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6339591A (ja) * 1986-08-04 1988-02-20 Nippon Kayaku Co Ltd 新規生理活性物質NK−A−17−e−233およびその製造法
JPS63307872A (ja) * 1987-06-09 1988-12-15 Nippon Kayaku Co Ltd 新規生理活性物質NK−A−17−e−233−4およびその製造法

Also Published As

Publication number Publication date
KR940004128B1 (ko) 1994-05-13
DE68906248T2 (de) 1993-08-12
KR900008048A (ko) 1990-06-02
DE68906248D1 (de) 1993-06-03
US5151529A (en) 1992-09-29
EP0371762A2 (en) 1990-06-06
CA2003956A1 (en) 1990-05-28
EP0371762B1 (en) 1993-04-28
EP0371762A3 (en) 1991-03-20
ATE88707T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
NO912630D0 (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler.
AR241008A1 (es) Procedimiento para el montaje de un ascensor y el ascensor obtenido por el mismo''
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2124479T3 (es) Composiciones biocidas.
ATE200279T1 (de) Herstellung von 3,4,4-trisubstituiertem piperidinyl-n-alkylcarboxylaten und zwischenverbindungen, verwendbar als opioid antagonisten
EP0620251A3 (en) Miscible polyolefin blends.
FI921345A0 (fi) Piperidinderivat.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
ITMI920526A1 (it) Tassani di interesse oncologico, loro metodo di preparazione ed uso
EP0318084A3 (en) Benzoheterazoles
SE8902076D0 (sv) Derivatives of quinoline-3-carboxanilide
MX9303585A (es) 3,4-dimetil-2,5,6-tris(p-sulfonatofenil)-1-fosfanorbornadieno, procedimiento para su preparacion y procedimiento para la hidroformilacion de compuestos olefinicamente insaturados.
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
PT91203A (pt) Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem
ES2055104T3 (es) Un procedimiento para preparar un compuesto que tiene actividad antagonista de fap.
EP0116150A3 (en) Pharmaceutically active heterocyclic compounds containing at least four ring-nitrogen atoms, their preparation and fermentation broths of aspergillus alliaceus atcc 20655 and 20656
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
ES2046178T3 (es) Metodo de uso de diltiazen, verapamil o nifedipina que presentan actividad para el tratamiento de ataques de apoplejia.
EA199800889A1 (ru) Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция
IT1216560B (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
DE69006931D1 (de) Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DK0755942T3 (da) N-amidino-dermorfin-derivat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 371762

Country of ref document: ES